Clinical Trial Update: A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating STA-4783 in combination with weekly paclitaxel for soft tissue sarcoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• STA-4783 (STA-4783)

Snippet

Sponsor: Synta Pharmaceuticals Corp. | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED